RNU7-154P

Across TCGA pan-cancer cohorts, RNU7-154P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU7-154P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU7-154P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-154P expression acts as an unfavorable survival marker, although some lineages such as LIHC and LUSC show a favorable association.

THCA, READ, and LIHC are the cancer types where RNU7-154P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	II,III,IV	0.744	0.928	<.001	96	view →
READ	DFS	Tertile	III,IV	0.403	0.775	<.001	48	view →
LIHC	OS	Quartile	II,III,IV	0.860	0.659	.004	43	view →
LUSC	OS	Tertile	III,IV	0.694	0.483	.017	11	view →
KICH	DFS	Tertile	III,IV	0.043	0.897	.045	9	view →
PAAD	DFS	Tertile	II,III,IV	0.298	0.455	.027	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
KIRC	DFS	Tertile	All	0.856	0.754	.038	6	view →
KIRP	DFS	Tertile	All	0.756	0.924	.032	6	view →
SKCM	OS	Median	IV	1.000	0.364	.020	4	view →
LUAD	OS	Tertile	III,IV	0.433	0.224	.044	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU7-154P–THCA (DFS)

Open the THCA breakdown →